Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Burns: where are we standing with propranolol,...
Journal article

Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?

Abstract

PURPOSE OF REVIEW: The hypermetabolic response in critically ill patients is characterized by hyperdynamic circulatory, physiologic, catabolic and immune system responses. Failure to satisfy overwhelming energy and protein requirements after, and during critical illness, results in multiorgan dysfunction, increased susceptibility to infection, and death. Attenuation of the hypermetabolic response by various pharmacologic modalities is emerging …

Authors

Gauglitz GG; Williams FN; Herndon DN; Jeschke MG

Journal

Current Opinion in Clinical Nutrition & Metabolic Care, Vol. 14, No. 2, pp. 176–181

Publisher

Wolters Kluwer

Publication Date

March 2011

DOI

10.1097/mco.0b013e3283428df1

ISSN

1363-1950